Latest News
BrightFocus Foundation, a nonprofit organization funding scientific research to end diseases of mind and sight, Alzheimer’s, macular degeneration and glaucoma, announced a special program, Brain Info Live: A Fireside Chat for Caregivers with Richard Lui.
A genetic mutation is found to impair lipid metabolism and function of microglia, key defensive players in the brain.
Researchers discover 10 new gene variants that increase the risk of Alzheimer’s disease (AD), including some on rare genes that were never before linked to AD.
Learn about the amazing breakthroughs in Alzheimer's Disease Research for summer 2021.
Brain tissue grown in a dish called an “organoid,” was used to study how genetic mutations contribute to FTD.
BrightFocus-funded researchers have proposed a new way to treat Alzheimer’s, by clearing toxic tau from the connections, or synapses, between brain cells.
BrightFocus is funding early science behind a promising new technology– a wearable device that provides a very early prediction of Alzheimer’s onset.
Researchers uncover a potential association between an APOE genetic variant and changes in brain metabolism leading to increased risk of Alzheimer’s disease and cognitive impairment.
BrightFocus funds investigator-initiated research around the globe on a wide range of approaches to understanding and intervening with the biological mechanisms of dementia. The foundation has a strong record of support for innovative research ideas from scientists in the early stages of their careers.
